TY - JOUR
T1 - Neuropsychiatric disorders in chronic kidney disease
AU - Silva, Ana Cristina Simões
AU - Miranda, Aline Silva
AU - Rocha, Natalia Pessoa
AU - Teixeira, Antônio Lúcio
N1 - Publisher Copyright:
Copyright © 2019 Simões e Silva, Miranda, Rocha and Teixeira.
PY - 2019
Y1 - 2019
N2 - Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression.
AB - Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression.
KW - Anxiety
KW - Cerebrovascular disease
KW - Chronic kidney disease
KW - Cognition
KW - Depression
KW - Neuropsychiatric disorders
UR - http://www.scopus.com/inward/record.url?scp=85071333526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071333526&partnerID=8YFLogxK
U2 - 10.3389/fphar.2019.00932
DO - 10.3389/fphar.2019.00932
M3 - Review article
AN - SCOPUS:85071333526
SN - 1663-9812
VL - 10
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
IS - JULY
M1 - 932
ER -